Understanding the Differences Between Benefit-Cost Analysis and Cost-Effectiveness Analysis AEA Coffee Break Demonstration October 27, 2011.

Slides:



Advertisements
Similar presentations
Step 4: Strategy Implementation. Learning Objectives Understand the elements and benefits of developing an action plan Value the involvement of internal.
Advertisements

OFFICE OF INFORMATION AND REGULATORY AFFAIRS ERS Risk Assessment, Economic Analysis, and Foodborne Illness Regulations Conference Dominic J. Mancini, OMB-OIRA.
Cost-Effectiveness Using Decision-Analytic Models
A Framework for Minnesota
Cost Assessment of Collaborative Healthcare
Constructing a cost-effectiveness analysis for a vaccine to prevent rotavirus Roseann Dial RN N287E.
Benefit-Cost in Practice: Implementing the Efficiency Standard.
Economic Analysis and Management Todd Wagner, PhD.
Recommendations for Conducting Cost Effectiveness: Elements of the Reference Case Ciaran S. Phibbs, Ph.D. February 25, 2009.
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Value Based Insurance Design Michael Chernew Feb 22, 2008 Portions of this research were funded by Pfizer and GSK.
1 Presented by Donald S. Shepard, Ph.D. Schneider Institute for Health Policy Heller School, Room 122A, Mail Stop 035 Brandeis University Waltham, MA
CER Needs from a state health policy perspective: California Health Benefits Review Program Susan Philip, MPP California Health Benefits Review Program.
Schneider Institute for Health Policy Heller School Brandeis University September Donald S. Shepard, Ph.D. Schneider Institute for Health Policy.
The Panel on Cost-Effectiveness in Health and Medicine Marthe Gold City University of London 30 October, 2003.
AGEC 608 Lecture 17, p. 1 AGEC 608: Lecture 17 Objective: Review the main aspects of cost- effectiveness analysis (CEA) and cost-utility analysis (CUA).
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 4 Economic Evaluation in Health Care.
Public Finance (MPA405) Dr. Khurrum S. Mughal. Lecture 12: Cost-Benefit Analysis and Government Investments Public Finance.
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
Benefit/Cost Analysis Lecture slides to accompany
© 2012 by McGraw-Hill, New York, N.Y All Rights Reserved 9-1 Lecture slides to accompany Engineering Economy 7 th edition Leland Blank Anthony Tarquin.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
impact of OPERATIONS SPENDING impact of STUDENT SPENDING impact of ALUMNI.
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
Economics of Implementation: Moving beyond Traditional CEA Mark Smith Paul Barnett VA Health Economics Resource Center.
PHAR 310: Pharmacoeconomics
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
What cost evidence supports the use of technologies in home and community based caregiving of older adults? Presented by Brooke Harrow, PhD University.
Normative Criteria for Decision Making Applying the Concepts
Health Economics Unit Definition of Economics  Demand − relationship between quantities and prices that addresses how much bought at each price.
Phaedra Corso, Ph.D. Associate Professor College of Public Health University of Georgia Program Evaluation from an Economic Perspective.
Estimating Incremental Cost- Effectiveness Ratios from Cluster Randomized Intervention Trials M. Ashraf Chaudhary & M. Shoukri.
Police DRUG POLICY And PROGRAMS. Harm Minimisation Supply Reduction Demand Reduction Harm Reduction.
Measuring Efficiency CRJS 4466EA. Introduction It is very important to understand the effectiveness of a program, as we have discovered in all earlier.
1 Presented by Donald S. Shepard, Ph.D. Schneider Institute for Health Policy Heller School, Room 122A, Mail Stop 035 Brandeis University Waltham, MA
Recommendations for Conducting Cost Effectiveness: Elements of the Reference Case Ciaran S. Phibbs, Ph.D. September 14, 2011.
© 2012 by McGraw-Hill All Rights Reserved 9-1 Lecture slides to accompany Engineering Economy 7 th edition Leland Blank Anthony Tarquin Chapter 9 Benefit/Cost.
PHARMACOECONOMICS Dr. Mohammad Aljawadi, PharmD PhD Department of Clinical Pharmacy King Saud University Aug, 2015 PHCL 431.
Copyright © 2009 Pearson Addison-Wesley. All rights reserved. Chapter 3 Valuing the Environment: Methods.
PGEU Symposium 15 June 2004 Contribution to the Panel discussion Claudio Lepori Member of the AESGP Board AESGP Offices : 7, Avenue de Tervuren, B-1040.
HIV/AIDS Track Session. Key Points Application of international reference price list during a national tender is a valuable tool for achieving optimal.
The financial costs and benefits of alcohol The financial costs and benefits of alcohol Christine Godfrey Department of Health Sciences & Centre for Health.
The Role of Perspective in Economic Evaluation for Cancer Prevention Steven Kymes, Ph.D. Research Associate Professor of Ophthalmology And Visual Sciences.
Capital Insight Pty Limited ABN Berry Street North Sydney NSW 2060 t f Health Economics.
Cost-Benefit Analysis and Government Investments
Cost-Effectiveness and Outcomes Research Setting value to what we do.
How Much Do SBHCs Cost? NASBHC’s Cost Survey NASBHC’s Cost Survey ©
Farid Abolhassani Cost-Benefit Analysis 18. Learning Objectives After working through this chapter, you will be able to: Define and give examples of health.
CRJS 4466 PROGRAM & POLICY EVALUATION LECTURE #6 Evaluation projects Questions?
FY 2013–14 DEMONSTRATING The VALUE of the UNIVERSITY OF IDAHO Analysis of the economic impact and return on investment of education.
Economic Studies in D&I Research Debra P. Ritzwoller Institute for Health Research Kaiser Permanente Colorado Evaluation and Measurement CRISP D&I Training.
COST ANALYSIS WITH IMPERFECT DATA EXAMPLES FROM INTERNATIONAL DEVELOPMENT KERI CULVER, SENIOR EVALUATION SPECIALIST MANAGEMENT SYSTEMS INTERNATIONAL/COFFEY.
David J. Cohen, M.D., M.Sc. Director of Cardiovascular Research
Burden of Disease and Health Economics: Friends or Foes?
Economic Contribution of
Cost effectiveness Analysis: Valuing Health; Valuing Research!
Chapter 10: Cost-Effectiveness and Cost Analysis Designs
HEALTH ECONOMICS BASICS
Academy on Violence and Abuse
Proposition 64 County Behavioral Health Directors Association
How to Perform a Cost-Effectiveness Analysis
EWG Study Tour, Galway, 18/09/2006
David J. Cohen, M.D., M.Sc. Director of Cardiovascular Research
Cost Effective Studies
Proposition 64 County Behavioral Health Directors Association
Economic Contribution of
Austin Community College
BAB 4 KOS KEMALANGAN.
Presentation Developed for the Academy of Managed Care Pharmacy
Rita Faria, MSc Centre for Health Economics University of York, UK
Presentation transcript:

Understanding the Differences Between Benefit-Cost Analysis and Cost-Effectiveness Analysis AEA Coffee Break Demonstration October 27, 2011

Introduction BCA and CEA are methods used in Economic Evaluation What is Economic Evaluation? Applied analytic methods to: Identify, Measure, Value, and Compare the costs and consequences of interventions, policies, strategies.

Step 1: Estimating Costs Programmatic Cost Analysis (CA) estimates total costs of running a program, intervention, policy –Micro-costing approach (not macro-view re: from budget) (Q 1 x P 1 ) + (Q 2 x P 2 ) +…. = TC Q = –Personnel –Facilities –Equipment –Supplies P = “value,” not price –Includes economic, not financial, costs Important for realizing costs from varying perspectives: provider, participant, societal

Ritzwoller, Sukhanova, Gaglio, & Glasgow. (2009). Costing behavioral interventions: A practical guide to enhance translation. Annals of Behavioral Medicine, 37:

Benefit-Cost Analysis CEA US Congress Allocation decision between 2 or more inter- ventions impacting impacting disparate outcomes Outcome comparator: $ Local Agency Allocation decision between 2 or more interventions designed to impact the same outcome Outcome comparator: Cases of X Tier of Decision Making Step 2: Comparing Costs to Outcomes

Benefit-Cost Analysis (BCA) Compares costs and benefits of an intervention. –Standardizes all costs and benefits in monetary terms. Lists all costs and benefits over time: –Can have different time lines for costs and benefits. –Can include health and non-health benefits. Used primarily in regulatory policy analyses. –Clean Water Act, Clean Air Act

BCA — Summary Measures Benefit-cost ratio (B/C). –Very popular with stakeholders. –“For every dollar spent on X, you will save Y dollars.” –Implement if B/C ratio > 1. –Often misleading. Easy to manipulate costs to get higher ratios. Net benefit (B – C). –Subtract costs from benefits. –Implement if net benefit > 0. –Less easily manipulated.

Quantify Benefits – One Approach Includes all direct costs saved –Example: medical treatment –Example: special education Includes a measure of indirect costs saved on productivity –Example: time lost from work due to illness –Example: wages lost because lower level of education

Example (Mudharri, US EPA, 1994) –BCA of a national smoke-free law for all public buildings with 10+ persons entering per week –Costs Implementation of the restriction, construction and maintenance of smoking lounges, and enforcement. –Benefits Direct: –Savings on medical expenditures by averting heart disease –Costs averted by reduced smoking-related fires Indirect: –Productivity gains –The value of lives saved –The net present benefit to society was between $42 and $78 billion, and this range was based on high and low estimates of costs and benefits.

Cost-Effectiveness Analysis (CEA) Estimates costs and outcomes of interventions. Expresses outcomes in natural units –Those identified by the Evaluator Compares results with other interventions affecting the same outcome.

Summary Measure - The C/E Ratio There MUST be a comparator that the program or intervention of interest is compared to –Choice of comparator always use best available intervention always include most widely used intervention Changes in resource use, relative to a comparator, are in the numerator and valued in monetary terms Main effects of the intervention, relative to a comparator, are in the denominator (Net) cost /outcome achieved –cost per case (of disease/injury/illness) prevented –Cost per 1% reduction in crime –Cost per 1% increase in HS graduation rate –cost per life saved; cost per life year saved

Example

CEA Caveat Outcomes cannot be combined; they must be considered separately. Consider one or two of the most important measures. Number of summary measures depends on number of outcomes chosen. –If A and B are the most important, then: Cost/outcome A. Cost/outcome B. Translation for policy-makers can be difficult.

Final Comments Economic evaluation (EE) methods are valuable to decision making and for setting policy. For practitioners and evaluators, these skills are necessary because the DEMAND for these analyses is growing.

Resources Health: –Applying cost analysis to PH interventions (for sale at –Drummond ME, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the Evaluation of Health Care Programmes, third edition. Oxford: Oxford Medical Publications, –Haddix AC, Teutsch SM, Corso PS., eds. Prevention Effectiveness: An Introduction to Decision Analysis and Economic Evaluation, second edition. New York, NY: Oxford University Press, –Gold MR, Siegel JE, Russel LB, Weinstein MC, eds. Cost- effectiveness in Health and Medicine. New York, NY: Oxford University Press, Education: –Levin & McEwan. Cost-Effectiveness Analysis. Sage Publications, 2001.

Thank You!